miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy

Xu, WP; Liu, JP; Feng, JF; Zhu, CP; Yang, Y; Zhou, WP; Ding, J; Huang, CK; Cui, YL; Ding, CH; Zhang, X; Lu, B; Xie, WF

Zhang, X; Xie, WF (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 20003, Peoples R China.; Lu, B (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Biochem Pharm, Shanghai 200433, Peoples R China.

GUT, 2020; 69 (7): 1309